Statement on Deviation or Variation for proceeds of public issue for the half year ended 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shanmuga Hospital has confirmed that all proceeds from its February 2025 IPO, totalling Rs. 2,061.72 lakhs, have been used exactly as disclosed in the offer document with no deviations. Of this, Rs. 1,452.50 lakhs was earmarked for capital expenditure; Rs. 337 lakhs had been spent by March 31, 2025, and the remaining Rs. 1,115.50 lakhs was fully utilised in May 2025 for the purchase and installation of a robotic surgical machine. Issue-related expenses (Rs. 225.94 lakhs) and general corporate purposes (Rs. 383.28 lakhs) had already been fully deployed earlier. The statement was reviewed by the Audit Committee and approved by the Board on November 12, 2025, and a chartered accountant's utilisation certificate was attached.
This is a routine regulatory filing, not a price-moving event in itself. For shareholders, it reinforces that management has honoured its stated IPO objectives on schedule, with the robotic surgical machine — a key growth asset — now fully procured. No negative signals; builds confidence in governance and execution credibility.